» Articles » PMID: 36846305

Muscle Health Patterns and Brain MRI Indices: A Cluster Analysis

Overview
Journal Innov Aging
Specialty Geriatrics
Date 2023 Feb 27
PMID 36846305
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: The interplay between muscle and brain lacks a holistic approach to assess the combined effect of multiple factors. This study utilizes clustering analysis to identify muscle health patterns and their relationships with various brain magnetic resonance imaging (MRI) indices.

Research Design And Methods: Two hundred and seventy-five cognitively intact participants who completed brain MRI from the Health, Aging, and Body Composition Study were enrolled. Muscle health-related markers that showed significant relationship with total gray matter volume entered the cluster analysis. Subsequently, macrostructural and microstructural MRI indices were examined with analysis of variance and multiple linear regression analysis to determine significant associations with muscle health clusters. The muscle health cluster included 6 variables: age, skeletal muscle mass index, gait speed, handgrip strength, change of total body fat, and serum leptin level. Clustering method produced 3 clusters which had characteristics of obese, leptin-resistant, and sarcopenia, respectively.

Results: Brain MRI indices that revealed significant associations with the clusters included gray matter volume (GMV) in cerebellum ( < .001), superior frontal gyrus ( = .019), inferior frontal gyrus ( = .003), posterior cingulum ( = .021), vermis ( = .045), and gray matter density (GMD) in gyrus rectus ( < .001) and temporal pole ( < .001). The leptin-resistant group had most degree of reduction in GMV, whereas the sarcopenia group had most degree of reduction in GMD.

Discussion And Implications: The leptin-resistant and sarcopenia populations had higher risk of neuroimaging alterations. Clinicians should raise awareness on the brain MRI findings in clinical settings. Because these patients mostly had central nervous system conditions or other critical illnesses, the risk of sarcopenia as a comorbidity will substantially affect the prognosis and medical care.

Citing Articles

Causal association of sarcopenia-related traits with brain cortical structure: a bidirectional Mendelian randomization study.

Zhan Y, Zhang Z, Lin S, Du B, Zhang K, Wu J Aging Clin Exp Res. 2025; 37(1):57.

PMID: 40014117 PMC: 11868162. DOI: 10.1007/s40520-025-02977-x.

References
1.
Arvanitakis Z, Fleischman D, Arfanakis K, Leurgans S, Barnes L, Bennett D . Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment. Brain Struct Funct. 2015; 221(4):2135-46. PMC: 4592368. DOI: 10.1007/s00429-015-1034-7. View

2.
Lieb W, Beiser A, Vasan R, Tan Z, Au R, Harris T . Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA. 2009; 302(23):2565-72. PMC: 2838501. DOI: 10.1001/jama.2009.1836. View

3.
Anderson V, Schott J, Bartlett J, Leung K, Miller D, Fox N . Gray matter atrophy rate as a marker of disease progression in AD. Neurobiol Aging. 2010; 33(7):1194-202. PMC: 3657171. DOI: 10.1016/j.neurobiolaging.2010.11.001. View

4.
Chang K, Hsu T, Wu W, Huang K, Han D . Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2016; 17(12):1164.e7-1164.e15. DOI: 10.1016/j.jamda.2016.09.013. View

5.
Greenlee J, Oya H, Kawasaki H, Volkov I, Severson 3rd M, Howard 3rd M . Functional connections within the human inferior frontal gyrus. J Comp Neurol. 2007; 503(4):550-9. DOI: 10.1002/cne.21405. View